179
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Wheat germ agglutinin-functionalised crosslinked polyelectrolyte microparticles for local colon delivery of 5-FU: in vitro efficacy and in vivo gastrointestinal distribution

, , , , , & show all
Pages 643-656 | Received 03 Sep 2012, Accepted 07 Jan 2013, Published online: 02 Apr 2013

References

  • Anande NM, Jain SK, Jain NK. Con-A conjugated mucoadhesive microspheres for the colonic delivery of diloxanide furoate. Int J Pharm 2008; 359: 182–9
  • Arias J. Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems. Molecules 2008; 13: 2340–69
  • Azab A, Kleinstern J, Srebnik M, Rubinstein A. The metastatic stage-dependent mucosal expression of sialic acid is a potential marker for targeting colon cancer with cationic polymers. Pharm Res 2008; 25: 379–86
  • Casey DL, Beihn RM, Digenis GA, Shambhu MB. Method for monitoring hard gelatin capsule disintegration times in humans using external scintigraphy. J Pharm Sci 1976; 65: 1412–13
  • Choi S-W, Shane B, Selhub J. Effect of methotrexate and 5-fluorouracil on de novo thymidylate synthesis in human colon carcinoma cell line, Caco-2. J Nutr Biochem 1996; 7: 513–17
  • De Dosso S, Sessa C, Saletti P. Adjuvant therapy for colon cancer: Present and perspectives. Cancer Treat Rev 2009; 35: 160–6
  • Dittmann H, Jusufoska A, Dohmen BM, Smyczek-Gargya B, Fersis N, Pritzkow M, Kehlbach R, Vonthein R, Machulla HJ, Bares R. 3′-Deoxy-3′-[18F]fluorothymidine (FLT) uptake in breast cancer cells as a measure of proliferation after doxorubicin and docetaxel treatment. Nucl Med Biol 2009; 36: 163–9
  • Dutta RK, Sahu S. Development of a novel probe sonication assisted enhanced loading of 5-FU in SPION encapsulated pectin nanocarriers for magnetic targeted drug delivery system. Eur J Pharm Biopharm 2012; 82: 58–65
  • Gabor F, Bogner E, Weissenboeck A, Wirth M. The lectin–cell interaction and its implications to intestinal lectin-mediated drug delivery. Adv Drug Deliver Rev 2004; 56: 459–80
  • Glavas Dodov M, Calis S, Crcarevska MS, Geskovski N, Petrovska V, Goracinova K. Wheat germ agglutinin-conjugated chitosan–Ca–alginate microparticles for local colon delivery of 5-FU: Development and in vitro characterization. Int J Pharm 2009; 381: 166–75
  • Glavas Dodov M, Geskovski N, Steffansen B, Kuzmanovska S, Simonoska Crcarevska M, Petrovska V, Goracinova K. Polyelectrolite complex based microspheres for colon specific anticancer drug delivery. Drug Discov Today 2010; 15: 1097
  • He W, Du Q, Cao D-Y, Xiang B, Fan L-F. Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in rats. Int J Pharm 2008; 348: 35–45
  • Heinrich EL, Welty LAY, Banner LR, Oppenheimer SB. Direct targeting of cancer cells: A multiparameter approach. Acta Histochem 2005; 107: 335–44
  • Hoffart V, Lamprecht A, Maincent P, Lecompte T, Vigneron C, Ubrich N. Oral bioavailability of a low molecular weight heparin using a polymeric delivery system. J Control Release 2006; 113: 38–42
  • Holt PR, Kozuch P, Mewar S. Colon cancer and the elderly: From screening to treatment in management of GI disease in the elderly. Best Pract Res Cl Ga 2009; 23: 889–907
  • Imoto M, Azuma H, Yamamoto I, Otagiri M, Imai T. Permeability of 5-fluorouracil and its prodrugs in Caco-2 cell monolayers: Evidence for shift from paracellular to transcellular transport by prodrug formation. J Drug Deliv Sci Tec 2009; 19: 37–41
  • Jain SK, Agrawal GP, Jain NK. A novel calcium silicate based microspheres of repaglinide: In vivo investigations. J Control Release 2006; 113: 111–16
  • Jin X, Zhang ZH, Sun E, Qian Q, Tan XB, Jia XB. Preparation of a nanoscale baohuoside I-phospholipid complex and determination of its absorption: In vivo and in vitro evaluations. Int J Nanomedicine 2012; 7: 4907–16
  • Lai P-S, Shieh M-J, Pai C-L, Wang C-Y, Young T-H. A pH-sensitive EVAL membrane by blending with PAA. J Membrane Sci 2006; 275: 89–96
  • Lee SJ, Kim SY, Chung JH, Oh SJ, Ryu JS, Hong YS, Kim TW, Moon DH. Induction of thymidine kinase 1 after 5-fluorouracil as a mechanism for 3′-deoxy-3′-[18F]fluorothymidine flare. Biochem Pharmacol 2010; 80: 1528–36
  • Leong KH, Chung LY, Noordin MI, Onuki Y, Morishita M, Takayama K. Lectin-functionalized carboxymethylated kappa-carrageenan microparticles for oral insulin delivery. Carbohyd Polym 2011; 86: 555–65
  • Liu Y, Wang P, Sun C, Feng N, Zhou W, Yang Y, Tan R, Chen Z, Wu S, Zhao J. Wheat germ agglutinin-grafted lipid nanoparticles: Preparation and in vitro evaluation of the association with Caco-2 monolayers. Int J Pharm 2010; 397: 155–63
  • Minko T. Drug targeting to the colon with lectins and neoglycoconjugates. Adv Drug Deliver Rev 2004; 56: 491–509
  • Miyazaki K, Shibahara T, Sato D, Uchida K, Suzuki H, Matsui H, Yanaka A, Nakahara A, Matsuzaki Y. Influence of chemotherapeutic agents and cytokines on the expression of 5-fluorouracil-associated enzymes in human colon cancer cell lines. J Gastroenterol 2006; 41: 140–50
  • Mladenovska K, Raicki RS, Janevik EI, Ristoski T, Pavlova MJ, Kavrakovski Z, Dodov MG, Goracinova K. Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles. Int J Pharm 2007; 342: 124–36
  • Moutardier V, Tosini F, Vlieghe P, Cara L, Delpero JR, Clerc T. Colloidal anticancer drugs bioavailabilities in oral administration models. Int J Pharm 2003; 260: 23–38
  • Mukhopadhyay A, Mukhopadhyay B, Basu SK. Circumvention of multidrug resistance in neoplastic cells through scavenger receptor mediated drug delivery. FEBS Lett 1995; 376: 95–8
  • Nielsen CU, Amstrup J, Steffansen B, Frokjaer S, Brodin B. Epidermal growth factor inhibits glycylsarcosine transport and hPepT1 expression in a human intestinal cell line. Am J Physiol-Gastr L 2001; 281: G191–9
  • Oosegi T, Onishi H, Machida Y. Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan–prednisolone conjugate microspheres in rats with TNBS-induced colitis. Int J Pharm 2008; 348: 80–8
  • Patel MM, Patel SL, Bhadani MN, Shah TJ, Amin AF. A synchronous colon-specific drug delivery system for orally administered mesalamine. Acta Pharma Sci 2009; 51: 251–60
  • Pellegrina CD, Perbellini O, Scupoli MT, Tomelleri C, Zanetti C, Zoccatelli G, Fusi M, Peruffo A, Rizzi C, Chignola R. Effects of wheat germ agglutinin on human gastrointestinal epithelium: Insights from an experimental model of immune/epithelial cell interaction. Toxicol Appl Pharmacol 2009; 237: 146–53
  • Risques RA, Lai LA, Himmetoglu C, Ebaee A, Li L, Feng Z, Bronner MP, Al-Lahham B, Kowdley KV, Lindor KD, et al. Ulcerative colitis–associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. Cancer Res 2011; 71: 1669–79
  • Sajeesh S, Bouchemal K, Sharma CP, Vauthier C. Surface-functionalized polymethacrylic acid based hydrogel microparticles for oral drug delivery. Eur J Pharm Biopharm 2010; 74: 209–18
  • Simon M, Behrens I, Dailey LA, Wittmar M, Kissel T. Nanosized insulin-complexes based on biodegradable amine-modified graft polyesters poly[vinyl-3-(diethylamino)-propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft-poly(L-lactic acid): Protection against enzymatic degradation, interaction with Caco-2 cell monolayers, peptide transport and cytotoxicity. Eur J Pharm Biopharm 2007; 66: 165–72
  • Simonoska Crcarevska M, Glavas Dodov M, Petrusevska G, Gjorgoski I, Goracinova K. Bioefficacy of budesonide loaded crosslinked polyeletrolyte microparticles in rat model of induced colitis. J Drug Target 2009; 17: 788–802
  • Singh B, Sharma N. Mechanistic implication for cross-linking in sterculia-based hydrogels and their use in GIT drug delivery. Biomacromolecules 2009; 10: 2515–32
  • Terzić J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 2010; 138: 2101–14.e5
  • Thompson C, Ibie C. The oral delivery of proteins using interpolymer polyelectrolyte complexes. Ther Deliv 2011; 2: 1611–31
  • Wahlang B, Pawar YB, Bansal AK. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur J Pharm Biopharm 2011; 77: 275–82
  • Wang C, Ho PC, Lim LY. Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells. Int J Pharm 2010; 400: 201–10
  • Warr JR, Bamford A, Quinn DM. The preferential induction of apoptosis in multidrug-resistant KB cells by 5-fluorouracil. Cancer Lett 2002; 175: 39–44
  • Wood KM, Stone GM, Peppas NA. The effect of complexation hydrogels on insulin transport in intestinal epithelial cell models. Acta Biomater 2010; 6: 48–56
  • Yan C, Chen D, Gu J, Qin J. Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: Preparation, characterization – in-vitro drug release and anti-tumour activity. J Pharm Pharmacol 2006; 58: 1177–81
  • Yau K, Price P, Pillai R, Aboagye E. Elevation of radiolabelled thymidine uptake in RIF-1 fibrosarcoma and HT29 colon adenocarcinoma cells after treatment with thymidylate synthase inhibitors. Eur J Nucl Med Mol I 2006; 33: 981–7
  • Yin Y, Chen D, Qiao M, Lu Z, Hu H. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin. J Control Release 2006; 116: 337–45
  • Zambito Y, Baggiani A, Carelli V, Serafini MF, Di Colo G. Matrices for site-specific controlled-delivery of 5-fluorouracil to descending colon. J Control Release 2005; 102: 669–77
  • Zhang N, Yin Y, Xu S-J, Chen W-S. 5-Fluorouracil: Mechanisms of resistance and reversal strategies. Molecules 2008; 13: 1551–69

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.